Onclive articles Copyright (c) 2014 Intellisphere, LLC. All rights reserved. http://www.onclive.com/articles Onclive articles Onclive articles en-us Mon, 03 Aug 2015 00:27:13 UTC 5 Onclive articles 144 47 http://www.onclive.com/articles http://www.onclive.com/media/image/35ab4bcc0544887940a968b55494cbb1.jpg <![CDATA[Targeting HER2 in NSCLC Remains Work in Progress]]>http://www.onclive.com/web-exclusives/targeting-her2-in-nsclc-remains-a-work-in-progressOnclive articlesusSun, 02 Aug 2015 00:05:00 UTCOnclive<![CDATA[Immune Checkpoint Combination Strategies Evolving in NSCLC]]>http://www.onclive.com/web-exclusives/immune-checkpoint-combination-strategies-evolving-in-nsclcOnclive articlesusSat, 01 Aug 2015 20:09:00 UTCOnclive<![CDATA[Translational Advances Deliver Precision Medicine to NSCLC]]>http://www.onclive.com/web-exclusives/translational-advances-deliver-precision-medicine-to-nsclcOnclive articlesusFri, 31 Jul 2015 22:06:00 UTCOnclive<![CDATA[Explosion in Next-Generation Agents on Horizon in NSCLC]]>http://www.onclive.com/web-exclusives/explosion-in-next-generation-agents-on-horizon-in-nsclcOnclive articlesusFri, 31 Jul 2015 21:40:00 UTCOnclive<![CDATA[Researcher Responsible for CLL Breakthroughs Honored by ASH]]>http://www.onclive.com/web-exclusives/researcher-responsible-for-cll-breakthroughs-honored-by-ashOnclive articlesusFri, 31 Jul 2015 14:44:00 UTCOnclive<![CDATA[Neoadjuvant Pertuzumab Regimen Approved in Europe for HER2-Positive Early Breast Cancer]]>http://www.onclive.com/web-exclusives/neoadjuvant-pertuzumab-regimen-approved-in-europe-for-her2-positive-early-breast-cancerOnclive articlesusFri, 31 Jul 2015 07:56:00 UTCOnclive<![CDATA[Regulatory Approval Sought for Eribulin in Soft Tissue Sarcoma]]>http://www.onclive.com/web-exclusives/regulatory-approval-sought-for-eribulin-in-soft-tissue-sarcomaOnclive articlesusThu, 30 Jul 2015 19:15:00 UTCOnclive<![CDATA[Idelalisib Use Expands With New CLL Indication Pending]]>http://www.onclive.com/web-exclusives/idelalisib-use-expands-with-new-cll-indication-pendingOnclive articlesusThu, 30 Jul 2015 15:57:00 UTCOnclive<![CDATA[Ibrutinib Induces Impressive Response in DLBCL Subtype]]>http://www.onclive.com/web-exclusives/ibrutinib-induces-impressive-response-in-dlbcl-subtypeOnclive articlesusThu, 30 Jul 2015 12:57:00 UTCOnclive<![CDATA[Concurrent Statin Use in ADT Patients Reduced All Cause, Prostate Cancer-Specific Deaths]]>http://www.onclive.com/publications/urologists-in-cancer-care/2015/August-2015/concurrent-statin-use-in-adt-patients-reduced-all-cause-prostate-cancer-specific-deathsOnclive articlesusWed, 29 Jul 2015 16:56:00 UTCOnclive